Loading clinical trials...
Loading clinical trials...
Treatment of Patients With Chronic Hepatitis C Co-infected With HIV Relapsers or Non Responders, Previous Exposed to Sub-optimal Therapies: Open, Pilot Trial
Conditions
Interventions
Peginterferon alfa-2a plus ribavirin adjusted to body weight
Locations
1
Spain
Hospital Carlos III
Madrid, Madrid, Spain
Start Date
March 1, 2006
Primary Completion Date
December 1, 2008
Completion Date
December 1, 2008
Last Updated
September 7, 2009
NCT06694805
NCT04142047
NCT07428330
NCT07225530
NCT05897099
NCT06665646
Lead Sponsor
Hospital Carlos III, Madrid
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions